Skip to main content
. 2019 Jul 23;106(6):1222–1235. doi: 10.1002/cpt.1540

Figure 2.

Figure 2

Chronic obstructive pulmonary disease (COPD) drug pipeline. The COPD indication pipeline is robust with a number of novel mechanisms and targets. Listing obtained from Clarivate Analytics Cortellis (Philadelphia, PA) database and literature review.17 CFTR, cystic fibrosis transmembrane conductance regulator; MARCKS, myristoylated alanine‐rich C‐kinase substrate; NK, natural killer.